Prosorba: CYPB began a pivotal trial in patients who have failed second-line, disease-modifying therapies

Cypress Bioscience Inc. (CYPB), San Diego, Calif. Product: Prosorba, Protein A-matrix plasmapheresis column Indication: Rheumatoid arthritis Status: CYPB began a pivotal trial in up to 250 patients w...